Extrahepatic manifestations of chronic hepatitis C and their influence on response to treatment with Pegylated interferon alfa-2a and ribavirin

Extrahepatic manifestations of chronic hepatitis C and their influence on response to treatment with Pegylated interferon alfa-2a and ribavirin

Introduction. Thirty to 50% of patients with chronic hepatitis C (CHC) have one or more extrahepatic manifestations (EHMs) of hepatitis C virus (HCV) infection. Objective. The aim of this study was to evaluate the frequency of EHMs and to investigate the efficacy of pegylated interferon (Peg­IFN)...

Full description

Bibliographic Details
Main Authors: Fabri Milotka, Ružić Maja, Lendak Dajana, Preveden Tomislav, Fabri Izabela, Petrić Vedrana
Format: Article
Language:English
Published: Serbian Medical Society 2013-01-01
Series:Srpski Arhiv za Celokupno Lekarstvo
Subjects:
chronic hepatitis C
extrahepatic manifestations
autoimmune hepatitis
Online Access:http://www.doiserbia.nb.rs/img/doi/0370-8179/2013/0370-81791306320F.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0370-8179/2013/0370-81791306320F.pdf

Similar Items